(Q43078049)

13 November 2017

title

A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro (English)

1 reference

13 November 2017

0 references

4

Arjan W Griffioen

1 reference

13 November 2017

Xander M R van Wijk

1

1 reference

13 November 2017

Arie Oosterhof

2

1 reference

13 November 2017

Sebastiaan A M W van den Broek

3

1 reference

13 November 2017

Gerdy B ten Dam

5

1 reference

13 November 2017

Floris P J T Rutjes

6

1 reference

13 November 2017

Floris L van Delft

7

1 reference

13 November 2017

Toin H van Kuppevelt

8

1 reference

13 November 2017

language of work or name

English

0 references

publication date

28 April 2010

1 reference

Experimental Cell Research

13 November 2017

published in

1 reference

13 November 2017

volume

316

1 reference

13 November 2017

issue

15

1 reference

13 November 2017

page(s)

2504-2512

1 reference

Order out of chaos: assembly of ligand binding sites in heparan sulfate

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Heparan sulphate proteoglycans fine-tune mammalian physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Functions of cell surface heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Roles of heparan-sulphate glycosaminoglycans in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

HSulf-1 inhibits angiogenesis and tumorigenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

The sweet and sour of cancer: glycans as novel therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Synthesis of 4-deoxy analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-xylose and their effects on glycoconjugate biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Biological evaluation of a series of 2-acetamido-2-deoxy-D-glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Generation of C-Glycoside Peptide Ligands for Cell Surface Carbohydrate Receptors Using a Four-Component Condensation on Solid Support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

A new method for the deoxygenation of secondary alcohols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Anti-tumor activity of the novel angiogenesis inhibitor anginex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Mice deficient in Ext2 lack heparan sulfate and develop exostoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Regulation of heparan sulfate and chondroitin sulfate glycosaminoglycan biosynthesis by 4-fluoro-glucosamine in murine airway smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

An essential heparin-binding domain in the fibroblast growth factor receptor kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Heparinase inhibits neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

O-linked glycan expression during Drosophila development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2010.04.025

1 reference

13 November 2017

1 reference